CB(1) antagonism restores hepatic insulin sensitivity without normalization of adiposity in diet-induced obese dogs.

Kim, Stella P; Woolcott, Orison O; Hsu, Isabel R; Stefanoski, Darko; Harrison, L Nicole; Zheng, Dan; Lottati, Maya; Kolka, Cathryn; Catalano, Karyn J; Chiu, Jenny D; Kabir, Morvarid; Ionut, Viorica; Bergman, Richard N; Richey, Joyce M

Kim, Stella P; Woolcott, Orison O; Hsu, Isabel R; Stefanoski, Darko; Harrison, L Nicole; Zheng, Dan; Lottati, Maya; Kolka, Cathryn; Catalano, Karyn J; Chiu, Jenny D; Kabir, Morvarid; Ionut, Viorica; Bergman, Richard N; Richey, Joyce M.

Affiliation

Kim SP; Dept. of Physiology and Biophysics, Univ. of Southern California Keck School of Medicine, 1333 San Pablo St. MMR 626, Los Angeles, CA 90033, USA. Stella.Kim@csmc.edu

Am J Physiol Endocrinol Metab ; 302(10): E1261-8, 2012 May 01.

Article in En | MEDLINE | ID: mdl-22374758

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperidines / Pyrazoles / Insulin Resistance / Receptor, Cannabinoid, CB1 / Liver / Obesity Type of study: Diagnostic_studies Limits: Animals Language: En Journal: Am J Physiol Endocrinol Metab Journal subject: ENDOCRINOLOGIA / FISIOLOGIA / METABOLISMO Year: 2012 Document type: Article Affiliation country: Estados Unidos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google